Managing Complex Biomarker Data

QuartzBio's Adam S. Brown, PhD, Senior Director of Product Support, will join experts from Washington University and Dana Farber Cancer Institute in a panel discussion, "Towards Precision Medicine: Oncological Applications of Data Integration" | May 18, 2:40 PM ET The panelists will share ideas for how to bring oncologists together with data integration leaders to systematically assess factors contributing to disease. Read More →

QuartzBio’s team has deep experience in technology-enabled solutions for the life science industry. In this blog series, we invited you to get to know a member of the QuartzBio team.

This month, we are delighted to talk with Mike Waters, QuartzBio Vice President of Sales. After learning about Mike here, please feel free to connect with him on LinkedIn.

1. In your own words, what do you do?
   My team and I provide solutions to help pharmaceutical and biotechnology companies accelerate the development of new treatments for the patients that need them. We encourage our customers Read More →

Duration: 30 minutes

Register to Watch Webinar On Demand:

Biomarker data can be time-consuming to clean and prepare for analysis, because assay results data files are often disconnected and have inconsistent formats.

This “data chaos” prevents translational, clinical, and bioinformatics teams from extracting insights to advance therapeutic development.

Join the webinar led by Adam Brown and Mike Waters, who will show how using a unified biomarker data management solution to acquire and process biomarker data, connected to clinical and sample data, empowers teams to break down Read More →

Translational and clinical teams spend more than 70% of their time managing, cleaning, and harmonizing data generated in biomarker-rich clinical programs. In a recent webinar, Adam Brown demonstrated how the QuartzBio® enterprise Biomarker Data Management (eBDM) solution addresses one set of frequently intractable challenges: connecting raw, processed, and ancillary data across multiple clinical studies. Read More →